
An online tool developed by Moffitt Cancer Center researchers, in collaboration with scientists at Ponce Health Sciences University in Puerto Rico helps determine the genetic ancestral origin of more than 1300 different cell lines. The findings of the study are published in Cancer Research.
Cancer is a highly varied disease, with genetic differences among different tumor types, individuals and ancestral populations. These genetic differences can impact disease aggressiveness, the type of disease, and the response to therapy. It is important that scientists have proper tools and model systems to study how these variations affect cancer development and devise effective therapies for patients of all genetic backgrounds.
In cancer research, cell lines established from patient tumors are used in laboratory experiments as model systems to understand the molecular and cellular basis of cancer, identify therapeutic targets and develop novel treatments. However, the genetic ancestry of these cell lines is often unknown or incomplete. As a result, scientific data may not accurately reflect the diverse populations that exist throughout the world, resulting in less effective patient management and treatments for different populations.
With the information they obtained, the team created an online, interactive web-based tool that allows researchers to determine the genetic ancestry of cell lines. "This information can be used by scientists as a data and visualization tool to show the genetic ancestry of the cell lines they are using for experiments," said Steven Eschrich, PhD, lead author of the article and senior member of the Biostatistics and Bioinformatics Department at Moffitt. "We believe that this new tool, representing diverse ancestries, will be an important resource to reduce the knowledge gaps that exist about disease prevention and treatment among diverse ancestral populations."
"We expect this resource to allow researchers access to ancestry in cell line models and to contribute to efforts to address the underrepresentation in cancer types with clear disparities. Incorporating estimated genetic ancestry within cell line molecular biology and drug discovery studies can significantly improve the rigor, reproducibility and relevance of cancer research activities, not just those explicitly examining the role of genetic ancestry in cancer biology," said Julie Dutil, Ph.D., professor at Ponce Health Sciences University.
Source: Eurekalert
Advertisement
|
Recommended Reading
Latest Cancer News




